Search research articles
Contact Us
Filters
Showing results (11-20 of 96) with videos related to
Page
of 10
Sort By:
British Journal of Pharmacology
|
November 18, 2000
Endomorphin-1 induced desensitization and down-regulation of the recombinant mu-opioid receptor
C Harrison, D J Rowbotham, D K Grandy, et al.
Peptides
|
September 22, 2000
Integrity of tritiated orphanin FQ/nociceptin: implications for establishing a reliable binding assay
D I Quigley, S Arttamangkul, R G Allen, et al.
Journal of Neurochemistry
|
December 1, 1992
Differential sensitivity of the short and long human dopamine D2 receptor subtypes to protein kinase C
Y F Liu, O Civelli, D K Grandy, et al.
Molecular Pharmacology
|
June 1, 1995
Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine
S A Hjorth, K Thirstrup, D K Grandy, et al.
Journal of Neurochemistry
|
May 1, 1995
Differential coupling of D1 and D5 dopamine receptors to guanine nucleotide binding proteins in transfected GH4C1 rat somatomammotrophic cells
K Kimura, S Sela, C Bouvier, et al.
Neuroscience Letters
|
August 29, 1997
Coupling of the cloned rat kappa-opioid receptor to adenylyl cyclase is dependent on receptor expression
R A Hirst, K Hirota, D K Grandy, et al.
Neuroreport
|
January 14, 1998
Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ
M M Morgan, J E Grisel, C S Robbins, et al.
Neuroendocrinology
|
March 21, 1998
The peptide orphanin FQ inhibits beta-endorphin neurons and neurosecretory cells in the hypothalamic arcuate nucleus by activating an inwardly-rectifying K+ conductance
E J Wagner, O K Rønnekleiv, D K Grandy, et al.
Endocrinology
|
October 28, 1999
Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice
S L Asa, M A Kelly, D K Grandy, et al.
Neuroreport
|
September 2, 1996
Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide
J E Grisel, J S Mogil, J K Belknap, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 96) with videos related to
Sort By:
Page
of 10
British Journal of Pharmacology
|
November 18, 2000
Endomorphin-1 induced desensitization and down-regulation of the recombinant mu-opioid receptor
C Harrison, D J Rowbotham, D K Grandy, et al.
Peptides
|
September 22, 2000
Integrity of tritiated orphanin FQ/nociceptin: implications for establishing a reliable binding assay
D I Quigley, S Arttamangkul, R G Allen, et al.
Journal of Neurochemistry
|
December 1, 1992
Differential sensitivity of the short and long human dopamine D2 receptor subtypes to protein kinase C
Y F Liu, O Civelli, D K Grandy, et al.
Molecular Pharmacology
|
June 1, 1995
Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine
S A Hjorth, K Thirstrup, D K Grandy, et al.
Journal of Neurochemistry
|
May 1, 1995
Differential coupling of D1 and D5 dopamine receptors to guanine nucleotide binding proteins in transfected GH4C1 rat somatomammotrophic cells
K Kimura, S Sela, C Bouvier, et al.
Neuroscience Letters
|
August 29, 1997
Coupling of the cloned rat kappa-opioid receptor to adenylyl cyclase is dependent on receptor expression
R A Hirst, K Hirota, D K Grandy, et al.
Neuroreport
|
January 14, 1998
Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ
M M Morgan, J E Grisel, C S Robbins, et al.
Neuroendocrinology
|
March 21, 1998
The peptide orphanin FQ inhibits beta-endorphin neurons and neurosecretory cells in the hypothalamic arcuate nucleus by activating an inwardly-rectifying K+ conductance
E J Wagner, O K Rønnekleiv, D K Grandy, et al.
Endocrinology
|
October 28, 1999
Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice
S L Asa, M A Kelly, D K Grandy, et al.
Neuroreport
|
September 2, 1996
Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide
J E Grisel, J S Mogil, J K Belknap, et al.
Page
of 10